Company profile: Myriad Genetics
1.1 - Company Overview
Company description
- Provider of genetic testing and molecular profiling solutions, including hereditary cancer risk assessment (MyRisk), pharmacogenomic testing for mental health medications (GeneSight), prostate cancer aggressiveness evaluation (Prolaris), tumor genomic profiling (Precise), carrier screening (Foresight), and non-invasive prenatal screening (Prequel).
Products and services
- MyRisk Hereditary Cancer Test: A genetic test that assesses the risk of developing 11 types of hereditary cancers, delivering personalized risk assessments and management strategies
- Precise Tumor Molecular Profile Testing: A comprehensive genomic profiling test for solid tumors, using next-generation sequencing to identify actionable genetic variants
- Prolaris Genetic Test: A genetic test for prostate cancer that evaluates the aggressiveness of the cancer to inform treatment decisions
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Myriad Genetics
Nerio Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology for the life sciences sector; founded in 2019 and based in La Jolla, CA, USA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nerio Therapeutics company profile →
Applied Proteomics
HQ: United States
Website
- Description: Provider of protein biomarker discovery solutions, including SimpliPro Colon Test—a blood test for healthcare providers to aid colorectal health assessment by measuring 11 protein markers associated with colorectal cancer and advanced adenoma—plus a mass-spectrometry (tandem LCMS) proteomics platform, proprietary workflow management system, and advanced visualization tools.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Applied Proteomics company profile →
Xcell Biosciences
HQ: United States
Website
- Description: Provider of a next-generation development and manufacturing platform for enhanced cell therapy performance, offering AVATAR Foundry, an automated closed system for autologous cell therapy production (in beta); AVATAR System, an incubator that fine-tunes oxygen and pressure to mimic in vivo; AVATAR AI, software using machine learning for drug behavior prediction and potency assay development; and AVATAR AD, a four-instrument system for assay development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Xcell Biosciences company profile →
Koelis
HQ: France
Website
- Description: Provider of medical imaging solutions for urologists, including KOELIS Trinity MRI/US prostate biopsy system for accurate needle guidance in prostate cancer diagnosis and treatment; OBT Fusion for prostate tracking and core location recording with precise targeting; 3D Ultrasound with motion compensation; 2nd Look Option; and transperineal and transrectal tools with 3D probes, holders, guides, and accessories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Koelis company profile →
ClearNote Health
HQ: United States
Website
- Description: Provider of cancer detection solutions, including the Avantect Pancreatic Cancer Test—a blood test that detects pancreatic cancer in its earliest stages by measuring the biomarker 5hmC; the Virtuoso Epigenomics Platform—a whole genome sequencing and 5hmC enrichment solution for revealing active disease biology for drug discovery and development; and targeted multi-cancer panels that track epigenomic signals via a single blood draw.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ClearNote Health company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Myriad Genetics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Myriad Genetics
2.2 - Growth funds investing in similar companies to Myriad Genetics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Myriad Genetics
4.2 - Public trading comparable groups for Myriad Genetics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →